Retention of bacterial lipopolysaccharide at the site of subcutaneous injection
about
Oral microbiome link to neurodegeneration in glaucomaIn vivo induction of apoptosis (programmed cell death) in mouse thymus by administration of lipopolysaccharide.Adjuvants for vaccines to drugs of abuse and addiction.Marked reduction of mouse peritoneal CD5+ B cells by intraperitoneal administration of lipopolysaccharide.Endotoxemia-menace, marker, or mistake?Expression of Fas and Fas ligand on mouse renal tubular epithelial cells in the generalized shwartzman reaction and its relationship to apoptosis.Complement-dependent accumulation and degradation of platelets in the lung and liver induced by injection of lipopolysaccharides.Differential release of smooth-type lipopolysaccharide from Pseudomonas aeruginosa treated with carbapenem antibiotics and its relation to production of tumor necrosis factor alpha and nitric oxide.Binding of mannose-binding protein to Klebsiella O3 lipopolysaccharide possessing the mannose homopolysaccharide as the O-specific polysaccharide and its relation to complement activation.Augmented immunological activities of recombinant lipopolysaccharide possessing the mannose homopolymer as the O-specific polysaccharide.Susceptibility of lipopolysaccharide-responsive and -hyporesponsive ItyS Mice to infection with rough mutants of Salmonella typhimurium.Novel adjuvant action of lipopolysaccharides that possess mannose homopolysaccharides as O-specific polysaccharides on immune responses to nonimmunogenic autoantigens in mice.In vivo production of heat shock protein in mouse peritoneal macrophages by administration of lipopolysaccharide.A murine model of experimental autoimmune lens-induced uveitis using Klebsiella O3 lipopolysaccharide as a potent immunological adjuvant.
P2860
Q27316016-60CBE41D-905E-41B8-A84B-556302A2193EQ33616311-9A6A0711-1BF3-4A38-8CEA-0C6373050E1CQ35493923-30102A42-E2EC-44E3-B649-93087D18BA5EQ35533549-EA44CD2F-48C0-4631-9983-7528DD6EDE1DQ38897447-73A4A162-D12F-4192-88DE-E08F03739223Q39511436-21910D4F-A580-49AE-9D5A-57E9893A0E8EQ39512262-B769CA58-7BB2-4588-AAD4-C5303834B952Q39783003-DE65944C-23D9-47A5-B4C1-CCCF9EB23BABQ39822400-84E5BEC5-6982-4DB9-8615-14B935B46656Q39824021-DAE24CCB-4778-4B6D-AF1B-39D1B8843710Q39824674-5EC20ACA-EC9F-49A9-A48C-C8E8721A681DQ40152336-97F6144B-112F-4CB4-B5B1-708001826A42Q40375483-1D04CEA8-FA07-43CF-9CB0-0640B7E68026Q41164711-3A468735-918C-4C79-8C3A-4EAE5669E410
P2860
Retention of bacterial lipopolysaccharide at the site of subcutaneous injection
description
1989 nî lūn-bûn
@nan
1989 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Retention of bacterial lipopolysaccharide at the site of subcutaneous injection
@ast
Retention of bacterial lipopolysaccharide at the site of subcutaneous injection
@en
type
label
Retention of bacterial lipopolysaccharide at the site of subcutaneous injection
@ast
Retention of bacterial lipopolysaccharide at the site of subcutaneous injection
@en
prefLabel
Retention of bacterial lipopolysaccharide at the site of subcutaneous injection
@ast
Retention of bacterial lipopolysaccharide at the site of subcutaneous injection
@en
P2093
P2860
P1476
Retention of bacterial lipopolysaccharide at the site of subcutaneous injection
@en
P2093
P2860
P304
P407
P577
1989-06-01T00:00:00Z